Atlas Trials

Transfusion Savings in Heart Surgery: Impact of Individual Strategy by Erythropoietin and Metabolic Adjustment (ScvO2)

Clinical trial NCT04141631 · COMPLETED

Trial details

NCT number
NCT04141631
Sponsor
University Hospital, Montpellier
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Cardiac SurgeryTransfusionPerioperative Anemia
Start date
2020-01-13
Primary completion
2022-05-10
Enrollment
128

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.